WHO confirms elimination of trachoma in South Asia

The world moved closer to eliminating trachoma this month after the World Health Organization (WHO) confirmed India and Pakistan as being free of the disease, a leading cause of blindness.

J&J backs down on plan to switch payments to some 340B hospitals

Under pressure from the Biden administration, Johnson & Johnson has decided not to alter payment methods for some hospitals that participate in a federal drug

September 30, 2024

Bayer inks deal to commercialize Mahana’s prescription digital therapeutics

Dive Brief: Bayer has formed a multi-million-dollar distribution and marketing partnership with the digital therapeutic developer Mahana Therapeutics. San Francisco-based Mahana received de novo clearance

August 23, 2023

Rucaparib camsylate by Pharmaand for Metastatic Pancreatic Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.